Cardiologist Makes a Federal Case Out of Retracted JAHA Paper medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
(UPDATED) Another observational study, in the form of a large analysis of US patients with hypertension, indicates that ACE inhibitors and ARBs are not associated with an increased risk of COVID-19 infection compared with use of other antihypertensive medications.
The study, appearing online December 14, 2020, ahead of print in the
Journal of the American Heart Association (JAHA), was swiftly followed by the largest meta-analysis to date this one published Friday in the
European Heart Journal: Cardiovascular Pharmacotherapy (EHJ:CP) also showing that ACE inhibitors/ARBs are safe and “should be continued” in patients with SARS-CoV-2.
Both papers join a series of epidemiologicstudies published in the last few months quelling the concerns raised earlier in the pandemic about the use of ACE inhibitors and ARBs in infected patients.
Teatime can be good for your health southernminn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southernminn.com Daily Mail and Mail on Sunday newspapers.
Posted By Ruth King on December 19th, 2020
A University of Pittsburgh cardiologist who faced backlash over an opinion piece he wrote criticizing affirmative action is suing his employers, the American Heart Association and the company that published and then retracted his article, alleging that he was demoted and defamed because his views were unpopular.
Dr. Norman C. Wang, who is a faculty member in Pitt’s School of Medicine and a doctor with University of Pittsburgh Physicians, was removed from his position as director of UPMC’s clinical cardiac electrophysiology fellowship program in August days after his article was noticed by other cardiologists on Twitter.